These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 11061852

  • 1. Evaluation of the effectiveness of targeted lookback for HCV infection in the United States-interim results.
    Culver DH, Alter MJ, Mullan RJ, Margolis HS.
    Transfusion; 2000 Oct; 40(10):1176-81. PubMed ID: 11061852
    [Abstract] [Full Text] [Related]

  • 2. HCV lookback in the United States: effectiveness of an extended lookback program.
    Menozzi D, Udulutch T, Llosa AE, Galel SA.
    Transfusion; 2000 Nov; 40(11):1393-8. PubMed ID: 11099671
    [Abstract] [Full Text] [Related]

  • 3. An evaluation of the process and costs associated with targeted lookbacks for HCV and general notification of transfusion recipients.
    Callum JL, Pinkerton PH, Coovadia AS, Thomson AE, Dewsbury F.
    Transfusion; 2000 Oct; 40(10):1169-75. PubMed ID: 11061851
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recent Canadian experience with targeted hepatitis C virus lookback.
    Goldman M, Patterson L, Long A.
    Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatitis C lookback in Canada.
    Goldman M, Long A.
    Vox Sang; 2000 May; 78 Suppl 2():249-52. PubMed ID: 10938962
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Targeted hepatitis C lookback: Quebec, Canada.
    Long A, Spurll G, Demers H, Goldman M.
    Transfusion; 1999 Feb; 39(2):194-200. PubMed ID: 10037131
    [Abstract] [Full Text] [Related]

  • 11. Probability of receiving testing in a national lookback program: the English HCV experience.
    Transfusion; 2002 Sep; 42(9):1140-5. PubMed ID: 12430670
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Retrospective targeted HCV lookback using centralized contracted notification service.
    Saxena S, Shulman IA, Pachciarz J, Downey N, Figueroa PI.
    Transfusion; 2003 Jun; 43(6):799-805. PubMed ID: 12757532
    [Abstract] [Full Text] [Related]

  • 14. Evaluating the impact of public health notification of suspected transfusion-transmissible hepatitis C virus infection and effectiveness of lookback and traceback investigations by Canadian Blood Services in British Columbia, Canada, August 2002 through February 2005.
    Whitlock M, Lord S, Buxton JA, Doyle P, Bigham M.
    Transfusion; 2007 Aug; 47(8):1534-9. PubMed ID: 17655599
    [Abstract] [Full Text] [Related]

  • 15. Health and economic consequences of HCV lookback.
    Pereira A.
    Transfusion; 2001 Jun; 41(6):832-9. PubMed ID: 11399829
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A study on the epidemiology of hepatitis C infection among blood donors in Singapore.
    Wang JE.
    J Public Health Med; 1995 Dec; 17(4):387-91. PubMed ID: 8639336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.